^
Association details:
Biomarker:No biomarker
Cancer:Penile Cancer
Drug:Erbitux (cetuximab) (EGFR inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Penile cancer: principles of systemic therapy…subsequent-line systemic therapy for metastatic/recurrent disease…useful in certain circumstances…cetuximab